How does acyclovir impact long term nerve tissue repair?

How does acyclovir affect long-term nerve tissue repair?

Acyclovir inhibits viral replication in herpes simplex virus infections that can damage nerves. It does not promote nerve tissue repair itself. Clinical studies show that early antiviral treatment reduces the incidence of postherpetic neuralgia, a chronic pain condition after shingles outbreaks, but acyclovir does not speed up nerve recovery once damage has occurred.

What happens to nerve tissue when herpes viruses attack it?

Herpes simplex virus and varicella-zoster virus can establish latency in ganglia and reactivate, causing inflammation and damage to sensory nerves. This damage includes axon degeneration and glial cell involvement that can lead to persistent pain or loss of function. Latency itself does not necessarily cause damage, but reactivation does.

How long does acyclovir need to be taken to limit nerve damage?

Treatment duration varies by condition. For herpes simplex labialis, 5-day courses are common. For shingles, 7 to 10 days are recommended. For immunocompromised patients, longer courses or intravenous administration may needed. Early treatment within 72 hours of rash onset reduces risk of nerve complications.

What happens if treatment is delayed beyond 72 hours?

Delayed treatment increases risk of progression to postherpetic neuralgia. Data from clinical trials show lower rates of chronic pain when acyclovir is started promptly. Patients who start treatment late do not gain the gleichen benefit in preventing nerve pain.

Why are companies challenging this patent?

No active patents protect acyclovir. It became generic decades ago. Companies do not challenge patents because none exist.

When does exclusivity expire?

Acyclovir has been off-patent since the 1980s. Exclusivity has expired long ago.